Neogenomics (NEO) FCF Margin (2010 - 2026)
Neogenomics' (NEO) quarterly FCF Margin came in at 5.82% in Q2 2026, down 190.0% YoY from 6.47% in Q2 2025, and up 182.73% on a QoQ basis from 7.04% in Q1 2026.
Neogenomics (NEO) FCF Margin (2010 - 2026) Analysis & Trends
Neogenomics (NEO) has 17 years of FCF Margin data on file, last reported at 5.82% in Q2 2026.
- Quarterly FCF Margin fell 190.0% year-over-year to 5.82% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.96% (up 182.0% YoY) and the FY2025 annual result came in at 2.99%, up 216.0% from the prior year.
- FCF Margin grew to 5.82% in Q2 2026, from 7.04% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 7.72% in Q2 2025 to a low of 31.8% in Q1 2022.
- A 5-year average of 7.58% and a median of 6.04% in 2023 frame the typical range for FCF Margin.
- The widest YoY moves for FCF Margin: up 1934 bps in 2022, down 2001 bps in 2022.
- Tracing NEO's FCF Margin over 5 years: stood at 5.93% in 2022, then jumped by 216 bps to 6.9% in 2023, then slumped by 115 bps to 1.05% in 2024, then sank by 228 bps to 3.43% in 2025, then surged by 270 bps to 5.82% in 2026.
- The last three FCF Margin figures came in at 5.82% (Q2 2026), 7.04% (Q1 2026), and 3.43% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 13.97% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 20.19% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 26.51% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 10.95% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.24% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 2.59% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 13.89% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 27.51% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn | 5.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.82% |
| Mar 31, 2026 | -7.04% |
| Dec 31, 2025 | -3.43% |
| Sep 30, 2025 | 0.30% |
| Jun 30, 2025 | 7.72% |
| Mar 31, 2025 | -17.75% |
| Dec 31, 2024 | -1.05% |
| Sep 30, 2024 | -0.93% |
| Jun 30, 2024 | 0.49% |
| Mar 31, 2024 | -20.16% |
| Dec 31, 2023 | 6.90% |
| Sep 30, 2023 | -6.43% |
| Jun 30, 2023 | -6.15% |
| Mar 31, 2023 | -16.48% |
| Dec 31, 2022 | -5.93% |
| Sep 30, 2022 | -18.73% |
| Jun 30, 2022 | -21.82% |
| Mar 31, 2022 | -31.80% |
| Dec 31, 2021 | -25.26% |
| Sep 30, 2021 | -18.74% |